Evidence map›Paper›PMID 41049303›Full record

ArticleAsiaIntervention2025

Double-kissing crush versus provisional stenting in patients with true coronary artery bifurcation lesions: a pooled individual patient-level analysis of randomised trials (DKCRUSH X trial).

Shao-Liang Chen, Jing Kan, Teguh Santoso, Tak W Kwan, Imad Sheiban, Tanveer S Rab, Muhammad Munawar, Wei-Hsian Yin, Fei Ye, Lianglong Chen and 3 more

Abstract read
In one paragraph

Article in AsiaIntervention, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

13 authors.

Shao-Liang ChenDepartment of Cardiology, Nanjing First Hospital, Nanjing Medical University, Nanjing, China.
Jing KanDepartment of Cardiology, Nanjing First Hospital, Nanjing Medical University, Nanjing, China.
Teguh SantosoDepartment of Cardiology, Medistra Hospital, Jakarta, Indonesia and University of Indonesia Medical School, Jakarta, Indonesia.
Tak W KwanDepartment of Cardiology, Lenox Hill Hospital, New York, NY, USA.
Imad SheibanDepartment of Cardiology, Pederzoli Hospital, Peschiera del Garda, Italy.
Tanveer S RabDivision of Cardiology, Emory University Hospital, Atlanta, GA, USA.
Muhammad MunawarDivision of Cardiology, Binawaluya Cardiac Center, Jakarta, Indonesia.
Wei-Hsian YinDivision of Cardiology, Cheng Hsin General Hospital, Taipei, Republic of China.
Fei YeDepartment of Cardiology, Nanjing First Hospital, Nanjing Medical University, Nanjing, China.
Lianglong ChenDepartment of Cardiology, Fujian Medical University Union Hospital, Fuzhou, China.
Junjie ZhangDepartment of Cardiology, Nanjing First Hospital, Nanjing Medical University, Nanjing, China.
Kwan Seung LeeDepartment of Cardiovascular Medicine, Mayo Clinic Arizona, Phoenix, AZ, USA.
On Behalf Of The Provisional Stenting Versus Systematic Two-Stent Dkcrush X Collaborator Group

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Background: Provisional stenting is the standard treatment for patients with coronary artery bifurcation lesions. Aims: This pooled individual patient data (IPD) analysis aims to evaluate the long-term (six-year) outcomes of provisional stenting versus upfront two-stent techniques in patients with true coronary bifurcation lesions treated with drug-eluting stents. Methods: A systematic review and IPD analysis of randomised trials with centrally adjudicated endpoints was conducted to assess the efficacy and safety of provisional stenting versus upfront two-stent approaches in patients with true coronary bifurcation lesions undergoing percutaneous coronary intervention with drug-eluting stents. All patients were prospectively followed, with their intervention having been completed at least six years earlier. The primary endpoint, re-evaluated by an independent clinical event committee, was target lesion failure (TLF) - a composite of cardiac death, target vessel myocardial infarction, or clinically driven target lesion revascularisation - assessed at the final follow-up on 8 November 2024. Results: A total of 6,225 citations were screened, and four randomised trials met the inclusion criteria. Among 1,573 patients in the intention-to-treat population, TLF at six years occurred in 144 patients (Kaplan-Meier estimate 18.2%) in the upfront two-stent group and 193 (Kaplan-Meier estimate 24.7%) in the provisional stenting group (hazard ratio [HR] 0.71, 95% confidence interval [CI]: 0.57-0.89; p=0.0022, τ²=0.00, I Conclusions: This IPD analysis provides robust long-term evidence that upfront two-stent techniques, particularly double-kissing crush stenting, significantly reduce TLF over a six-year follow-up period compared with provisional stenting, especially in patients with complex bifurcations.

Identifiers

PMID41049303
PMCPMC12494082

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.